PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
XBIT vs. IBB
Performance
Return for Risk
Drawdowns
Volatility
Dividends

XBIT vs. IBB

Last updated Jun 24, 2026

XBIT (XBiotech Inc.) is a stock, while IBB (iShares Nasdaq Biotechnology ETF) is Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index. Over the past 10 years, XBIT returned -17.34%/yr vs 8.21%/yr for IBB. At a 0.30 correlation, their price movements are largely independent.

Performance

XBIT vs. IBB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in XBiotech Inc. (XBIT) and iShares Nasdaq Biotechnology ETF (IBB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XBIT achieves a -2.51% return, which is significantly lower than IBB's 5.61% return. Over the past 10 years, XBIT has underperformed IBB with an annualized return of -17.34%, while IBB has yielded a comparatively higher 8.21% annualized return.

XBIT

1D
0.87%
1M
-4.12%
YTD
-2.51%
6M
-5.28%
1Y
-10.04%
3Y*
-27.20%
5Y*
-30.61%
10Y*
-17.34%

IBB

1D
0.62%
1M
5.52%
YTD
5.61%
6M
3.57%
1Y
42.90%
3Y*
11.80%
5Y*
2.21%
10Y*
8.21%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XBIT vs. IBB - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
XBIT
XBiotech Inc.		-2.51%-39.49%-1.25%13.96%-68.46%-17.46%-16.15%267.42%28.93%-61.07%
IBB
iShares Nasdaq Biotechnology ETF		5.61%27.98%-2.41%3.76%-13.69%0.95%26.01%25.42%-9.53%21.08%

Correlation

The correlation between XBIT and IBB is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (5Y)
Calculated over the trailing 5-year period

0.32

Correlation (10Y)
Calculated over the trailing 10-year period

0.31

Correlation (All Time)
Calculated using the full available price history since Apr 15, 2015

0.30

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

XBiotech Inc.

iShares Nasdaq Biotechnology ETF

Often compared with XBIT:
XBIT vs. XBIXBIT vs. XBIOXBIT vs. AHCOXBIT vs. IBIOXBIT vs. IHIXBIT vs. SPYL.DEXBIT vs. VHT
Often compared with IBB:
IBB vs. XBIIBB vs. ARKGIBB vs. XLVIBB vs. IBBQIBB vs. BBHIBB vs. SPYIBB vs. FBIOX

Return for Risk

XBIT vs. IBB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
XBIT
XBIT Risk / Return Rank: 3434
Overall Rank
XBIT Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
XBIT Sortino Ratio Rank: 3333
Sortino Ratio Rank
XBIT Omega Ratio Rank: 3333
Omega Ratio Rank
XBIT Calmar Ratio Rank: 3434
Calmar Ratio Rank
XBIT Martin Ratio Rank: 3636
Martin Ratio Rank
IBB
IBB Risk / Return Rank: 7171
Overall Rank
IBB Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
IBB Sortino Ratio Rank: 6868
Sortino Ratio Rank
IBB Omega Ratio Rank: 6060
Omega Ratio Rank
IBB Calmar Ratio Rank: 8585
Calmar Ratio Rank
IBB Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XBIT vs. IBB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

XBITIBBDifference
Sharpe ratioReturn per unit of total volatility
-0.20
2.12

-2.32

Sortino ratioReturn per unit of downside risk
0.06
2.96

-2.90

Omega ratioGain probability vs. loss probability

1.01

1.35

-0.34

Calmar ratioReturn relative to maximum drawdown

-0.26

4.47

-4.73

Martin ratioReturn relative to average drawdown

-0.37

13.77

-14.14

XBIT vs. IBB - Sharpe Ratio Comparison

The current XBIT Sharpe Ratio is -0.20, which is lower than the IBB Sharpe Ratio of 2.12. The chart below compares the historical Sharpe Ratios of XBIT and IBB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

XBIT vs. IBB - Drawdown Comparison

The maximum XBIT drawdown since its inception was -92.67%, which is greater than IBB's maximum drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for XBIT and IBB.

Loading charts...

Drawdown Indicators

XBITIBBDifference

Max Drawdown

Largest peak-to-trough decline

-92.67%

-62.85%

-29.82%

Max Drawdown (1Y)

Largest decline over 1 year

-39.43%

-9.63%

-29.80%

Max Drawdown (3Y)

Largest decline over 3 years

-78.56%

-24.85%

-53.71%

Max Drawdown (5Y)

Largest decline over 5 years

-87.21%

-39.82%

-47.39%

Max Drawdown (10Y)

Largest decline over 10 years

-90.72%

-39.82%

-50.90%

Current Drawdown

Current decline from peak

-91.42%

0.00%

-91.42%

Average Drawdown

Average peak-to-trough decline

-70.17%

-21.14%

-49.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

26.82%

3.12%

+23.70%

Volatility

XBIT vs. IBB - Volatility Comparison

The current volatility for XBiotech Inc. (XBIT) is 4.90%, while iShares Nasdaq Biotechnology ETF (IBB) has a volatility of 6.95%. This indicates that XBIT experiences smaller price fluctuations and is considered to be less risky than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

XBITIBBDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.90%

6.95%

-2.05%

Volatility (6M)

Calculated over the trailing 6-month period

21.88%

15.98%

+5.90%

Volatility (1Y)

Calculated over the trailing 1-year period

51.00%

20.34%

+30.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

64.05%

22.03%

+42.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.11%

23.17%

+51.94%

Dividends

XBIT vs. IBB - Dividend Comparison

XBIT has not paid dividends to shareholders, while IBB's dividend yield for the trailing twelve months is around 0.23%.

PositionTTM20252024202320222021202020192018201720162015
IBB
iShares Nasdaq Biotechnology ETF		0.23%0.23%0.29%0.26%0.31%0.21%0.21%0.33%0.20%0.30%0.19%0.03%
XBIT
XBiotech Inc.		0.00%0.00%0.00%0.00%0.00%22.46%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

XBIT and IBB have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBB has higher volatility (6.95%) compared to XBIT (4.90%). In terms of maximum drawdown, XBIT dropped -92.67% vs IBB's -62.85%.

IBB currently has the higher Sharpe Ratio (2.12 vs -0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XBIT and IBB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer